Valuation: Beijing Hotgen Biotech Co., Ltd.

Capitalization 8.78B 1.29B 1.11B 1.01B 960M 1.78B 124B 1.79B 12.1B 4.7B 58.82B 4.86B 4.75B 205B P/E ratio 2024
-29.9x
P/E ratio 2025 -64.8x
Enterprise value 7.47B 1.1B 943M 862M 816M 1.51B 105B 1.52B 10.29B 4B 50B 4.13B 4.04B 174B EV / Sales 2024
8.74x
EV / Sales 2025 32.3x
Free-Float
67.66%
Yield 2024 *
-
Yield 2025 -
1 day-2.52%
1 week-13.63%
Current month-11.87%
1 month-17.57%
3 months-27.69%
6 months-41.89%
Current year-38.96%
1 week 96.66
Extreme 96.66
115.79
1 month 96.66
Extreme 96.66
127.86
Current year 96.66
Extreme 96.66
214.78
1 year 96.66
Extreme 96.66
262.22
3 years 22.94
Extreme 22.94
262.22
5 years 22.94
Extreme 22.94
262.22
10 years 22.94
Extreme 22.94
262.22
Manager TitleAgeSince
Chief Executive Officer 50 2006-03-31
Director of Finance/CFO 46 2023-04-25
Investor Relations Contact - -
Director TitleAgeSince
Chairman 50 2014-01-31
Director/Board Member 56 2022-06-30
Director/Board Member 42 2022-06-30
Change 5d. change 1-year change 3-years change Capi.($)
-2.52%-13.63%-6.70%+124.17% 1.33B
+0.19%+6.94%+142.29%+253.75% 13.06B
-2.95%+1.97%-38.55%-25.40% 10.31B
+0.22%+6.23%+22.66%-2.56% 6.28B
-3.49%+3.02%-13.58%-8.83% 5.81B
+3.81%-23.14% - - 4.15B
+1.16%+8.72%+104.73%+97.54% 4.8B
-1.53%+10.50%-28.11%-34.22% 4.38B
-1.51%+0.92%-13.77%-40.92% 2.9B
+2.14%-4.01%+135.96%-60.01% 2.67B
Average -0.45%-0.12%+33.88%+33.72% 5.57B
Weighted average by Cap. -0.61%+2.96%+43.05%+61.87%

Financials

2024 2025
Net sales 511M 75.3M 64.51M 58.98M 55.85M 103M 7.2B 104M 704M 273M 3.42B 283M 277M 11.91B 405M 59.67M 51.12M 46.74M 44.26M 81.95M 5.71B 82.61M 558M 217M 2.71B 224M 219M 9.44B
Net income -191M -28.15M -24.12M -22.05M -20.88M -38.66M -2.69B -38.97M -263M -102M -1.28B -106M -103M -4.45B -216M -31.84M -27.28M -24.94M -23.62M -43.73M -3.04B -44.08M -298M -116M -1.45B -119M -117M -5.04B
Net Debt -1.07B -158M -135M -124M -117M -217M -15.11B -219M -1.48B -574M -7.18B -593M -581M -25B -1.32B -194M -166M -152M -144M -267M -18.55B -269M -1.81B -705M -8.82B -728M -713M -30.69B
Logo Beijing Hotgen Biotech Co., Ltd.
Beijing Hotgen Biotech Co Ltd is a China-based company principally engaged in in-vitro diagnostics, innovative biological drugs, and biotechnology raw materials and artificial intelligence (AI) innovative drug services. The in-vitro diagnostics business mainly engages in the development and application of in-vitro diagnostic reagents and instruments. The innovative biological drug business focuses on two core areas: antibody drugs and nucleic acid drugs. The biotechnology raw materials and AI innovative drug services business mainly includes the core technology platform of biotechnology raw materials and the biomolecular AI design platform. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
-
Date Price Change Volume
26-05-13 98.88 ¥ -2.52% 1,987,376
26-05-13 101.44 ¥ -5.22% 4,465,174
26-05-12 107.03 ¥ -5.98% 3,895,393
26-05-11 113.84 ¥ +1.72% 3,061,626
26-05-08 111.91 ¥ -0.44% 1,293,799

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688068 Stock